Antipsychotic-associated all-cause and cardiac mortality: what should we worry about and how should the risk be assessed?

被引:16
作者
Correll, Christoph U.
Nielsen, Jimmi
机构
关键词
SCHIZOPHRENIA; SERTINDOLE;
D O I
10.1111/j.1600-0447.2010.01610.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:341 / 344
页数:4
相关论文
共 6 条
[1]   Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians? [J].
Citrome, L. ;
Stroup, T. Scott .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (08) :933-940
[2]   Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) [J].
De Hert, M. ;
Dekker, J. M. ;
Wood, D. ;
Kahl, K. G. ;
Holt, R. I. G. ;
Moeller, H. -J. .
EUROPEAN PSYCHIATRY, 2009, 24 (06) :412-424
[3]  
KANE JM, 2010, 2 SCHIZ INT RES SOC
[4]   The effect of sertindole on QTD and TPTE [J].
Nielsen, J. ;
Andersen, M. P. ;
Graff, C. ;
Kanters, J. K. ;
Hardahl, T. ;
Dybbro, J. ;
Struijk, J. J. ;
Meyer, J. M. ;
Toft, E. .
ACTA PSYCHIATRICA SCANDINAVICA, 2010, 121 (05) :385-388
[5]   Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naive Schizophrenia Patients [J].
Nielsen, Jimmi ;
Skadhede, Soren ;
Correll, Christoph U. .
NEUROPSYCHOPHARMACOLOGY, 2010, 35 (09) :1997-2004
[6]   Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP) [J].
Thomas, S. H. L. ;
Drici, M. D. ;
Hall, G. C. ;
Crocq, M. A. ;
Everitt, B. ;
Lader, M. H. ;
Le Jeunne, C. ;
Naber, D. ;
Priori, S. ;
Sturkenboom, M. ;
Thibaut, F. ;
Peuskens, J. ;
Mittoux, A. ;
Tanghoj, P. ;
Toumi, M. ;
Moore, N. D. ;
Mann, R. D. .
ACTA PSYCHIATRICA SCANDINAVICA, 2010, 122 (05) :345-355